Medrobotics has received CE Mark approval for its Flex system, a robotic-assist platform that enables surgeons to gain single-site access and visualisation to difficult-to-access anatomical locations.
With this approval, Medrobotics will initiate a limited commercial launch of the Flex system in select European markets. The company prepares for the European commercialisation of the Flex system in otolaryngology.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Medrobotics claims that the robotic-assist platform enables physicians to navigate the Flex endoscope around anatomical structures to hard-to-reach locations through a single access site, and then use the onboard high-definition vision system to precisely deploy a range of third-party flexible surgical instruments.
The uniquely wristed 3mm Flex instruments enables the surgeon to operate in confined spaces. It provides a unique platform to access and visualize surgical targets in difficult to reach locations such as the oropharynx and endolarynx.
The Flex system is anticipated to provide a cost-effective, robot-assisted surgical platform for hospitals and surgeons eager to expand their offering of minimally-invasive treatment options to the broadest number of patients.
It provides a precise and stable platform for enhanced visualization and enables two-handed dexterousness with compatible third-party instruments having tactile feedback.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataMedrobotics president and CEO Dr Samuel Straface said the Flex system is the first robot-assisted flexible endoscopic platform for use during surgical procedures.
"The system enables surgeons to access and visualise hard-to-reach anatomical locations and deploy specially designed flexible surgical instruments to perform procedures," Dr Straface said.
In November 2013, Medrobotics gained ISO 13485: 2003 Certification for the design, manufacture, service and distribution of the Flex system.
Medrobotics medical advisory board co-chair, professor and chairman emeritus of Cleveland Clinic Head and Neck Institute Dr Marshall Strome said: "With currently available technologies, we are often trading off between access, visualisation and two-handed surgery, but the Flex System gives us all three."
According to GlobalData estimates, the Flexible endoscopes market in Europe was valued at $813.4m in 2012 and is expected to grow at a CAGR of 3.9% to reach $1.06bn by 2019.
